Millennium Management
GNMX

Millennium Management’s Aevi Genomic Medicine Inc GNMX Stock Holding History

Millennium Management’s Portfolio GNMX Stock Details GNMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-61,223
Closed -$43K – 4500
2018
Q4 		$43K Sell
61,223
-54,976
-47% -$61.4K ﹤0.01% 3627
2018
Q3 		$143K Buy
116,199
+60,208
+108% +$67.3K ﹤0.01% 3698
2018
Q2 		$62K Sell
55,991
-12,257
-18% -$18.6K ﹤0.01% 3691
2018
Q1 		$137K Sell
68,248
-18,455
-21% -$34.7K ﹤0.01% 3443
2017
Q4 		$104K Sell
86,703
-42,856
-33% -$58.5K ﹤0.01% 3652
2017
Q3 		$163K Sell
129,559
-39,663
-23% -$50.7K ﹤0.01% 3300
2017
Q2 		$225K Buy
169,222
+182
+0.1% +$263 ﹤0.01% 3153
2017
Q1 		$314K Sell
169,040
-193,660
-53% -$876K ﹤0.01% 3023
2016
Q4 		$1.88M Buy
+362,700
New +$1.91M ﹤0.01% 1912
2016
Q1 		– Sell
-32,581
Closed -$196K – 3830
2015
Q4 		$196K Buy
32,581
+7,581
+30% +$51.5K ﹤0.01% 3095
2015
Q3 		$196K Buy
+25,000
New +$194K ﹤0.01% 3123
2015
Q2 		– Sell
-24,108
Closed -$194K – 4051
2015
Q1 		$194K Buy
24,108
+13,724
+132% +$104K ﹤0.01% 3312
2014
Q4 		$53K Buy
+10,384
New +$51.3K ﹤0.01% 3825

Other funds holding GNMX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Millennium Management's GNMX Position: Q1 2019 in Review

Millennium Management sold out of Aevi Genomic Medicine Inc (GNMX) in Q1 2019, closing a stake of 61,223 shares — an estimated $43K sold.

Millennium Management first reported a position in GNMX in Q4 2014 and held it in 13 quarters. The position peaked at $1.88M in Q4 2016. 28 funds tracked by Wall St. Rank hold GNMX as of Q1 2019.

  • Millennium Management reported no remaining Aevi Genomic Medicine Inc position as of Q1 2019 after selling out during the quarter.
  • Millennium Management sold 61,223 Aevi Genomic Medicine Inc shares in Q1 2019, an estimated $43K.
  • Millennium Management first reported a position in Aevi Genomic Medicine Inc in Q4 2014 and held it in 13 quarters.
  • Millennium Management's Aevi Genomic Medicine Inc position peaked at $1.88M in Q4 2016.
  • 28 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q1 2019.

Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.